logo-loader
Cliintel Capital Management Group LLC

Cliintel Capital Management takes on Cannapharmarx, predicts revenues of C$25M

Cliintel Capital Management Group LLC Founding Partner Rick Batenburg III tells Proactive Investors that the private equity firm specializing in incubating cannabis companies, has taken on Canadian-based Cannapharmarx Inc (OTCMKTS:CPMD), saying the fund found the cannabis company attractive due to its ability to grow at large, industrial scale.

Batenburg says, in addition, the company has stabilized its energy cost by using an on-site power plant and using natural gas, and he expects the company to produce 110,000 kg of cannabis per year, expecting the company to pull in over C$25 million in 2019.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Alchemist sees big market in China for medical cannabis sales

Alchemist (CSE: AMS) CEO Paul Mann and Vice President of Business Development, Asia Pacific Johnson Lee joined Steve Darling from Proactive Vancouver to discuss Alchemist looking for opportunities for cannabis in the emerging cannabis market.  Mann and Lee talk about what the industry...

1 day, 15 hours ago

2 min read